LAUSANNE, Switzerland and SAN DIEGO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Argá Medtech today announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial, demonstrating the ...
- Second generation pulsed field ablation system will be evaluated in paroxysmal and persistent atrial fibrillation patients to gain FDA approval - The first patients were treated by Dr. Ante Anic, at ...
EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Argá Medtech announced today that it has begun enrollment in their First-in-Human Clinical Trial “Coherent Sine Burst Electroporation (CSE) ...
- Funding will advance US and EU clinical studies of innovative pulsed field ablation system for treating atrial fibrillation - Argá Medtech’s CSE™ ablation system enables electrophysiologists to ...
LAUSANNE, Switzerland and SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- Argá Medtech, a company developing Coherent Sine-Burst Electroporation (CSE), a next-generation non-thermal cardiac ablation ...
Argá Medtech SA said patients in the first stage of enrollment for a first-in-human clinical trial have been safely and effectively treated with an ablation system for treating atrial fibrillation (AF ...
WEYMOUTH, MA — Electro Switch Corp. has acquired Arga Controls, a producer of precision measurement and control instrumentation. Based in Monrovia, California, Arga Controls will operate as a unit of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results